Takashi Sawada

2PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 03, 2021
Predictability of Severe Adverse Events in Phase 3 Trials from Safety Information on Phase 1 Trials in Oncology Drug Development.

Takashi Sawada, Masayuki Kaneko, Mamoru Narukawa

Pageof 1

Frequent Collaborators